Food and Drug Administration Pharmaceutical manufacturing Safety Specialization 
Pharma Leaders
MAY 8, 2023
The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.
European Pharmaceutical Review
AUGUST 9, 2022
Burkholderia species are one of the primary causes of non-sterile pharmaceutical product recalls and accounted for 45.3 percent of recalls recorded by the US Food and Drug Administration (FDA) between 2012 and 2019. l), and iii) it can handle small amounts of reagents in a single reaction tube (up to a total volume of 10?l)
Expert insights. Personalized for you.
52 
Let's personalize your content